No photo of Barbara Rossetti

Barbara Rossetti

20192020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Barbara Rossetti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression

Antinori, A., Cossu, M. V., Menzaghi, B., Sterrantino, G., Squillace, N., Di Cristo, V., Cattelan, A., Focà, E., Castagna, A., Orofino, G., Valenti, D., D’Ettore, G., Aprea, L., Ferrara, S., Locatelli, M. E., Madeddu, G., Pontali, E., Scerbo, P., Rossetti, B., Uglietti, A. & 4 others, Termini, R., Rucci, F., Gori, A. & Mancusi, D., Apr 8 2020, In : Patient. p. 1-13 13 p.

Research output: Contribution to journal › Article

Open Access

    • Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014

    the ICONA Foundation Study Group, Feb 1 2019, In : HIV Medicine. 20, 2, p. 99-109 11 p.

    Research output: Contribution to journal › Article

    • Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study

    Modica, S., Redi, D., Gagliardini, R., Giombini, E., Bezenchek, A., Di Carlo, D., Maggiolo, F., Lombardi, F., Borghetti, A., Farinacci, D., Callegaro, A., Gismondo, M. R., Colafigli, M., Sterrantino, G., Costantini, A., Ferrara, S. M., Rusconi, S., Zazzi, M., Rossetti, B., De Luca, A. & 1 others, Gianotti, N., Oct 11 2019, In : The Journal of antimicrobial chemotherapy. 75, 1, p. 1-6 6 p.

    Research output: Contribution to journal › Article

    • Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

    ICONA Foundation Study group, Oct 15 2019, In : BMC Public Health. 19, 1, p. 1-13 13 p., 1291.

    Research output: Contribution to journal › Article

    Open Access

    • Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort

    Modica, S., Rossetti, B., Lombardi, F., Lagi, F., Maffeo, M., D'Autilia, R., Pecorari, M., Vicenti, I., Bruzzone, B., Magnani, G., Paolucci, S., Francisci, D., Penco, G., Sacchini, D., Zazzi, M., De Luca, A. & Di Biagio, A., Feb 2019, In : HIV Medicine. 20, 2, p. 137-146 10 p.

    Research output: Contribution to journal › Article